Lonza | LONN - Operating Profit



Lonza reported CHF430M in Operating Profit for its fiscal semester ending in December of 2024.


Operating Profit Change Date
Akzo Nobel EUR 303M 111M Jun/2025
Alcon AG USD 247M 221M Jun/2025
Almirall EUR 43.02M 8.82M Jun/2025
AstraZeneca USD 3.51B 166M Jun/2025
BASF EUR 827M 370M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Beiersdorf EUR 816M 370M Jun/2025
Covestro EUR 49M 146M Jun/2025
Demant DKK 1.87B 471M Jun/2025
Fresenius EUR 560M 127M Jun/2025
Fresenius Medical Care EUR 431M 100M Jun/2025
Geberit CHF 237.7M 38.5M Mar/2025
Genmab DKK 360M 172M Jun/2025
Givaudan CHF 364.5M 165.5M Jun/2024
GlaxoSmithKline GBP 2.02B 193M Jun/2025
GN Store Nord DKK 461M 246M Jun/2025
Hikma Pharmaceutical USD 282M 45M Dec/2024
Johnson Matthey GBP -37000000 612M Mar/2025
Merck EUR 1.03B 24M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Philips EUR 488M 334M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
Sanofi EUR 1.71B 573M Jun/2025
Sika AG CHF 417.05M 471.65M Jun/2024
Smith & Nephew USD 440M 111M Jun/2025
Solvay EUR 126M 27M Jun/2025
UCB EUR 1B 678M Dec/2024